Sex- and gender-specific disparities in colorectal cancer risk

World Journal of Gastroenterology

Volumn 21, Issue 17, 2015, Pages 5167-5175

  Kim, Sung Eun ^a   Paik, Hee Young ^b   Yoon, Hyuk ^c   Lee, Jung Eun ^a   Kim, Nayoung ^c   Sung, Mi Kyung ^a  

^a Sookmyung Women's University   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Colorectal cancer; Gender; Prevention; Screening; Sex; Treatment

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; CULTURAL FACTOR; DIETARY INTAKE; FALSE NEGATIVE RESULT; GENITAL SYSTEM; HUMAN; METABOLISM; MORBIDITY; PRACTICE GUIDELINE; QUALITY OF LIFE; SEX DIFFERENCE; SOCIAL ASPECT; STUDY DESIGN; SURVIVAL RATE; ADVERSE EFFECTS; AGED; COLORECTAL NEOPLASMS; DIET; EARLY CANCER DIAGNOSIS; FEMALE; HEALTH CARE DISPARITY; HEALTH DISPARITY; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENT;

AGED; ANTINEOPLASTIC AGENTS; COLONOSCOPY; COLORECTAL NEOPLASMS; DIET; EARLY DETECTION OF CANCER; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84929008294     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i17.5167     Document Type: Article

References (64)

1. Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer, 2013
2. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012; 44: 11-24 [PMID: 22500156 DOI: 10.4143/crt.2012.44.1.11]
3. Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H. Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2014; 44: 388-396 [PMID: 24503029 DOI: 10.1093/jjco/hyu003]
4. Hansen IO, Jess P. Possible better long-term survival in left versus right-sided colon cancer - a systematic review. Dan Med J 2012; 59: A4444 [PMID: 22677242]
5. Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 2010; 28: 4086-4093 [PMID: 20644100 DOI: 10.1200/jco.2009.27.0579]
6. Kaku E, Oda Y, Murakami Y, Goto H, Tanaka T, Hasuda K, Yasunaga M, Ito K, Sakurai K, Fujimori T, Hattori M, Sasaki Y. Proportion of flat- and depressed-type and laterally spreading tumor among advanced colorectal neoplasia. Clin Gastroenterol Hepatol 2011; 9: 503-508 [PMID: 21440090 DOI: 10.1016/j.cgh.2011.03.018]
7. Saunders BP, Fukumoto M, Halligan S, Jobling C, Moussa ME, Bartram CI, Williams CB. Why is colonoscopy more difficult in women? Gastrointest Endosc 1996; 43: 124-126 [PMID: 8635705]
8. Brenner H, Haug U, Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 2010; 105: 2457-2464 [PMID: 20700114 DOI: 10.1038/ajg.2010.301]
9. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191-1308 [PMID: 7017215]
10. Park HC, Shin A, Kim BW, Jung KW, Won YJ, Oh JH, Jeong SY, Yu CS, Lee BH. Data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry. Ann Coloproctol 2013; 29: 144-149 [PMID: 24032114 DOI: 10.3393/ac.2013.29.4.144]
11. Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010; 53: 57-64 [PMID: 20010352 DOI: 10.1007/DCR.0b013e3181c703a4]
12. Lieberman DA, Williams JL, Holub JL, Morris CD, Logan JR, Eisen GM, Carney P. Race, ethnicity, and sex affect risk for polyps > 9 mm in average-risk individuals. Gastroenterology 2014; 147: 351-358; quiz e14-15 [PMID: 24786894 DOI: 10.1053/j.gastro.2014.04.037]
13. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009; 361: 2449-2460 [PMID: 20018966 DOI: 10.1056/NEJMra0804588]
14. Jacobs ET, Thompson PA, Martínez ME. Diet, gender, and colorectal neoplasia. J Clin Gastroenterol 2007; 41: 731-746 [PMID: 17700421 DOI: 10.1097/MCG.0b013e3180338e56]
15. Missiaglia E, Jacobs B, D'Ario G, Di Narzo AF, Soneson C, Budinska E, Popovici V, Vecchione L, Gerster S, Yan P, Roth AD, Klingbiel D, Bosman FT, Delorenzi M, Tejpar S. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol 2014; 25: 1995-2001 [PMID: 25057166 DOI: 10.1093/annonc/mdu275]
16. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002; 101: 403-408 [PMID: 12216066 DOI: 10.1002/ijc.10635]
17. Lynch HT, Watson P, Lanspa SJ, Marcus J, Smyrk T, Fitzgibbons RJ, Kriegler M, Lynch JF. Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). Dis Colon Rectum 1988; 31: 439-444 [PMID: 3378468]
18. Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, Schaffer D, Samowitz WS. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001; 61: 126-130 [PMID: 11196149]
19. Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, Mason E, McNeeley SG, Ascensao J, Chlebowski RT. Conjugated equine estrogens and colorectal cancer incidence and survival: the Women' s Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2008; 17: 2609-2618 [PMID: 18829444 DOI: 10.1158/1055-9965.epi-08-0385]
20. Foster PA. Oestrogen and colorectal cancer: mechanisms and controversies. Int J Colorectal Dis 2013; 28: 737-749 [PMID: 23319136 DOI: 10.1007/s00384-012-1628-y]
21. Lin KJ, Cheung WY, Lai JY, Giovannucci EL. The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer 2012; 130: 419-430 [PMID: 21365647 DOI: 10.1002/ijc.26026]
22. Bae JM, Kim JH, Cho NY, Kim TY, Kang GH. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br J Cancer 2013; 109: 1004-1012 [PMID: 23900220 DOI: 10.1038/bjc.2013.430]
23. Wiencke JK, Zheng S, Lafuente A, Lafuente MJ, Grudzen C, Wrensch MR, Miike R, Ballesta A, Trias M. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 501-506 [PMID: 10385139]
24. Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Genderspecific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res 2008; 28: 1271-1276 [PMID: 18505065]
25. Phipps AI, Makar KW, Newcomb PA. Descriptive profile of PIK3CA-mutated colorectal cancer in postmenopausal women. Int J Colorectal Dis 2013; 28: 1637-1642 [PMID: 23728594 DOI: 10.1007/s00384-013-1715-8]
26. Lieberman DA, Holub J, Eisen G, Kraemer D, Morris CD. Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol 2005; 3: 798-805 [PMID: 16234009]
27. Eloubeidi MA, Wallace MB, Desmond R, Farraye FA. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer. Am J Gastroenterol 2003; 98: 1634-1639 [PMID: 12873591 DOI: 10.1111/j.1572-0241.2003.07480.x]
28. Farraye FA, Horton K, Hersey H, Trnka Y, Heeren T, Provenzale D. Screening flexible sigmoidoscopy using an upper endoscope is better tolerated by women. Am J Gastroenterol 2004; 99: 1074-1080 [PMID: 15180728 DOI: 10.1111/j.1572-0241.2004.30215.x]
29. Brenner H, Hoffmeister M, Arndt V, Haug U. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 2007; 96: 828-831 [PMID: 17311019 DOI: 10.1038/sj.bjc.6603628]
30. McCullogh JS, Ratcliffe B, Mandir N, Carr KE, Goodlad RA. Dietary fibre and intestinal microflora: effects on intestinal morphometry and crypt branching. Gut 1998; 42: 799-806 [PMID: 9691918]
31. Stark A, Nyska A, Madar Z. Metabolic and morphometric changes in small and large intestine in rats fed high-fiber diets. Toxicol Pathol 1996; 24: 166-171 [PMID: 8992606]
32. Wardle J, Haase AM, Steptoe A, Nillapun M, Jonwutiwes K, Bellisle F. Gender differences in food choice: the contribution of health beliefs and dieting. Ann Behav Med 2004; 27: 107-116 [PMID: 15053018]
33. Westenhoefer J. Age and gender dependent profile of food choice. Forum Nutr 2005; (57): 44-51 [PMID: 15702587]
34. Weinberg DS, Newschaffer CJ, Topham A. Risk for colorectal cancer after gynecologic cancer. Ann Intern Med 1999; 131: 189-193 [PMID: 10428735]
35. Amri R, Stronks K, Bordeianou LG, Sylla P, Berger DL. Gender and ethnic disparities in colon cancer presentation and outcomes in a US universal health care setting. J Surg Oncol 2014; 109: 645-651 [PMID: 24474677 DOI: 10.1002/jso.23567]
36. Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS, Matsuda T, Ng SS, Lau JY, Zheng S, Adler S, Reddy N, Yeoh KG, Tsoi KK, Ching JY, Kuipers EJ, Rabeneck L, Young GP, Steele RJ, Lieberman D, Goh KL. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 2015; 64: 121-132 [PMID: 24647008 DOI: 10.1136/gutjnl-2013-306503]
37. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: American Institute for Cancer Research, 2007
38. World Cancer Research Fund, American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer. Washington, DC: American Institute for Cancer Research, 2011
39. Borugian MJ, Sheps SB, Whittemore AS, Wu AH, Potter JD, Gallagher RP. Carbohydrates and colorectal cancer risk among Chinese in North America. Cancer Epidemiol Biomarkers Prev 2002; 11: 187-193 [PMID: 11867506]
40. McMichael AJ, Potter JD. Diet and colon cancer: integration of the descriptive, analytic, and metabolic epidemiology. Natl Cancer Inst Monogr 1985; 69: 223-228 [PMID: 3834337]
41. West DW, Slattery ML, Robison LM, Schuman KL, Ford MH, Mahoney AW, Lyon JL, Sorensen AW. Dietary intake and colon cancer: sex- and anatomic site-specific associations. Am J Epidemiol 1989; 130: 883-894 [PMID: 2554725]
42. Hu J, La Vecchia C, Negri E, Mery L. Nutrients and risk of colon cancer. Cancers (Basel) 2010; 2: 51-67 [PMID: 24281033 DOI: 10.3390/cancers2010051]
43. Hjartaker A, Aagnes B, Robsahm TE, Langseth H, Bray F, Larsen IK. Subsite-specific dietary risk factors for colorectal cancer: a review of cohort studies. J Oncol 2013; 2013: 703854 [PMID: 23577027 DOI: 10.1155/2013/703854]
44. Larsson SC, Rafter J, Holmberg L, Bergkvist L, Wolk A. Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort. Int J Cancer 2005; 113: 829-834 [PMID: 15499619 DOI: 10.1002/ijc.20658]
45. Ferrucci LM, Sinha R, Huang WY, Berndt SI, Katki HA, Schoen RE, Hayes RB, Cross AJ. Meat consumption and the risk of incident distal colon and rectal adenoma. Br J Cancer 2012; 106: 608-616 [PMID: 22166801 DOI: 10.1038/bjc.2011.549]
46. Stemmermann GN, Nomura A, Chyou PH. The influence of dairy and nondairy calcium on subsite large-bowel cancer risk. Dis Colon Rectum 1990; 33: 190-194 [PMID: 2311461]
47. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 2002; 94: 437-446 [PMID: 11904316]
48. Oh K, Willett WC, Wu K, Fuchs CS, Giovannucci EL. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 2007; 165: 1178-1186 [PMID: 17379616 DOI: 10.1093/aje/kwm026]
49. Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, Riboli E, Hercberg S, Norat T. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011; 20: 1003-1016 [PMID: 21378269 DOI: 10.1158/1055-9965.epi-10-1141]
50. Yan L, Spitznagel EL, Bosland MC. Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19: 148-158 [PMID: 20056634 DOI: 10.1158/1055-9965.epi-09-0856]
51. Yang G, Shu XO, Li H, Chow WH, Cai H, Zhang X, Gao YT, Zheng W. Prospective cohort study of soy food intake and colorectal cancer risk in women. Am J Clin Nutr 2009; 89: 577-583 [PMID: 19073792 DOI: 10.3945/ajcn.2008.26742]
52. Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 2006; 136: 3046-3053 [PMID: 17116718]
53. Budhathoki S, Joshi AM, Ohnaka K, Yin G, Toyomura K, Kono S, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R. Soy food and isoflavone intake and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Scand J Gastroenterol 2011; 46: 165-172 [PMID: 20969489 DOI: 10.3109/00365521.2010.522720]
54. Xu X, Duncan AM, Wangen KE, Kurzer MS. Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000; 9: 781-786 [PMID: 10952094]
55. Bises G, Bajna E, Manhardt T, Gerdenitsch W, Kallay E, Cross HS. Gender-specific modulation of markers for premalignancy by nutritional soy and calcium in the mouse colon. J Nutr 2007; 137: 211S-215S [PMID: 17182828]
56. Cercek A, Siegel CL, Capanu M, Reidy-Lagunes D, Saltz LB. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clin Colorectal Cancer 2013; 12: 163-167 [PMID: 23871161 DOI: 10.1016/j.clcc.2013.04.007]
57. O'Neill MT, Ni Dhonnchu T, Brannigan AE. Topic update: effects of colorectal cancer treatments on female fertility and potential methods for fertility preservation. Dis Colon Rectum 2011; 54: 363-369 [PMID: 21304311 DOI: 10.1007/DCR.0b013e31820240b3]
58. Warren RS, Atreya CE, Niedzwiecki D, Weinberg VK, Donner DB, Mayer RJ, Goldberg RM, Compton CC, Zuraek MB, Ye C, Saltz LB, Bertagnolli MM. Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803. Clin Cancer Res 2013; 19: 5777-5787 [PMID: 23983256 DOI: 10.1158/1078-0432.ccr-13-0351]
59. Ning Y, Gerger A, Zhang W, Hanna DL, Yang D, Winder T, Wakatsuki T, Labonte MJ, Stintzing S, Volz N, Sunakawa Y, Stremitzer S, El-Khoueiry R, Lenz HJ. Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy. Mol Cancer Ther 2014; 13: 528-539 [PMID: 24170770 DOI: 10.1158/1535-7163.mct-13-0646]
60. Oliver JS, Martin MY, Richardson L, Kim Y, Pisu M. Gender differences in colon cancer treatment. J Womens Health (Larchmt) 2013; 22: 344-351 [PMID: 23531098 DOI: 10.1089/jwh.2012.3988]
61. Sloan JA, Goldberg RM, Sargent DJ, Vargas-Chanes D, Nair S, Cha SS, Novotny PJ, Poon MA, O'Connell MJ, Loprinzi CL. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol 2002; 20: 1491-1498 [PMID: 11896096]
62. van der Geest LG, Portielje JE, Wouters MW, Weijl NI, Tanis BC, Tollenaar RA, Struikmans H, Nortier JW. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer. Colorectal Dis 2013; 15: e582-e591 [PMID: 23679338 DOI: 10.1111/codi.12288]
63. Paulson EC, Wirtalla C, Armstrong K, Mahmoud NN. Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum 2009; 52: 1982-1991 [PMID: 19959975 DOI: 10.1007/DCR.0b013e3181beb42a]
64. Dobie SA, Baldwin LM, Dominitz JA, Matthews B, Billingsley K, Barlow W. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst 2006; 98: 610-619 [PMID: 16670386 DOI: 10.1093/jnci/djj159]